Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

A new study has pitted Wegovy and Zepbound head-to-head in their ability to treat obesity. Published in The New England ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...